Short Original
Tocilizumab in the treatment of active chronic humoral rejection resistant to standard therapy
Tocilizumab en el tratamiento del rechazo humoral crónico activo resistente a terapia estándar
Betty Chamouna,
, Pablo Sánchez-Sanchob, Irina B. Torresa,
, Alejandra Gabaldonc, Manel Perellóa, Joana Sellarésa, Francesc Moresoa, Daniel Seróna
Corresponding author
Corresponding author
a Servicio de Nefrología, Hospital Universitari Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain
b Servicio de Farmacia, Hospital Universitari Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain
c Servicio de Patología, Hospital Universitari Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain
Read
2547
Timeswas read the article
1077
Total PDF
1470
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 54 | 37 | 91 |
| 2024 October | 73 | 45 | 118 |
| 2024 September | 71 | 36 | 107 |
| 2024 August | 79 | 78 | 157 |
| 2024 July | 68 | 32 | 100 |
| 2024 June | 70 | 47 | 117 |
| 2024 May | 58 | 44 | 102 |
| 2024 April | 77 | 43 | 120 |
| 2024 March | 56 | 33 | 89 |
| 2024 February | 45 | 43 | 88 |
| 2024 January | 61 | 31 | 92 |
| 2023 December | 46 | 35 | 81 |
| 2023 November | 68 | 34 | 102 |
| 2023 October | 73 | 54 | 127 |
| 2023 September | 53 | 37 | 90 |
| 2023 August | 82 | 42 | 124 |
| 2023 July | 77 | 68 | 145 |
| 2023 June | 92 | 81 | 173 |
| 2023 May | 86 | 72 | 158 |
| 2023 April | 54 | 60 | 114 |
| 2023 March | 70 | 56 | 126 |
| 2023 February | 54 | 66 | 120 |
| 2023 January | 3 | 3 | 6 |
Show all
